Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

被引：9
作者：
Derrick, Caroline B. [1 ]
Ostermann, Jan [2 ,3 ]
Weissman, Sharon B. [1 ]
Hobbie, Amy [3 ]
Alshareef, Noor [2 ]
Weinhold, Andrew [3 ]
Yelverton, Valerie [2 ,4 ]
Thielman, Nathan M. [3 ,5 ]
机构：
[1] Univ South Carolina, Sch Med, Dept Med, Columbia, SC 29208 USA
[2] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Serv Policy & Management, Columbia, SC 29208 USA
[3] Duke Univ, Duke Global Hlth Inst, Ctr Hlth Policy & Inequal Res, Durham, NC USA
[4] Hsch Neubrandenburg, Fachbereich Gesundheit, Pflege, Management, Neubrandenburg, Germany
[5] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2018年 / 5卷 / 10期
关键词：
antiretroviral therapy (ART) adherence; patient preferences; shared decision-making; treatment characteristics; HIV-1; INFECTION;
D O I：
10.1093/ofid/ofy247
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Study participants were asked about their interest in switching to novel drug delivery systems that reduce the dosing frequency of antiretroviral regimens. Across a diverse, treatment-experienced cohort, we describe greatest interest in switching to an oral regimen taken once weekly, followed by injections taken every other month and twice-annual implants.
引用
收藏
页数：3
相关论文
共 11 条
  • [1] Centers for Disease Control and Prevention, 2018, UND HIV CAR CONT
  • [2] Prevention of HIV-1 Infection with Early Antiretroviral Therapy
    Cohen, Myron S.
    Chen, Ying Q.
    McCauley, Marybeth
    Gamble, Theresa
    Hosseinipour, Mina C.
    Kumarasamy, Nagalingeswaran
    Hakim, James G.
    Kumwenda, Johnstone
    Grinsztejn, Beatriz
    Pilotto, Jose H. S.
    Godbole, Sheela V.
    Mehendale, Sanjay
    Chariyalertsak, Suwat
    Santos, Breno R.
    Mayer, Kenneth H.
    Hoffman, Irving F.
    Eshleman, Susan H.
    Piwowar-Manning, Estelle
    Wang, Lei
    Makhema, Joseph
    Mills, Lisa A.
    de Bruyn, Guy
    Sanne, Ian
    Eron, Joseph
    Gallant, Joel
    Havlir, Diane
    Swindells, Susan
    Ribaudo, Heather
    Elharrar, Vanessa
    Burns, David
    Taha, Taha E.
    Nielsen-Saines, Karin
    Celentano, David
    Essex, Max
    Fleming, Thomas R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (06) : 493 - 505
  • [3] Racial differences in attitudes toward innovative medical technology
    Groeneveld, Peter W.
    Sonnad, Seema S.
    Lee, Anee K.
    Asch, David A.
    Shea, Judy E.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 (06) : 559 - 563
  • [4] Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis
    Gunawardana, Manjula
    Remedios-Chan, Mariana
    Miller, Christine S.
    Fanter, Rob
    Yang, Flora
    Marzinke, Mark A.
    Hendrix, Craig W.
    Beliveau, Martin
    Moss, John A.
    Smith, Thomas J.
    Bauma, Marc M.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 3913 - 3919
  • [5] Increase in Single-Tablet Regimen Use and Associated Improvements in Adherence-Related Outcomes in HIV-Infected Women
    Hanna, David B.
    Hessol, Nancy A.
    Golub, Elizabeth T.
    Cocohoba, Jennifer M.
    Cohen, Mardge H.
    Levine, Alexandra M.
    Wilson, Tracey E.
    Young, Mary
    Anastos, Kathryn
    Kaplan, Robert C.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (05) : 587 - 596
  • [6] Implementation challenges for long-acting antivirals as treatment
    Havlir, Diane
    Gandhi, Monica
    [J]. CURRENT OPINION IN HIV AND AIDS, 2015, 10 (04) : 282 - 289
  • [7] Single tablet HIV regimens facilitate virologic suppression and retention in care among treatment naive patients
    Hemmige, Vagish
    Flash, Charlene A.
    Carter, Josephinel
    Giordano, Thomas P.
    Zerai, Teddy
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (08): : 1017 - 1024
  • [8] Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
    Kirtane, Ameya R.
    Abouzid, Omar
    Minahan, Daniel
    Bensel, Taylor
    Hill, Alison L.
    Selinger, Christian
    Bershteyn, Anna
    Craig, Morgan
    Mo, Shirley S.
    Mazdiyasni, Hormoz
    Cleveland, Cody
    Rogner, Jaimie
    Lee, Young-Ah Lucy
    Booth, Lucas
    Javid, Farhad
    Wu, Sarah J.
    Grant, Tyler
    Bellinger, Andrew M.
    Nikolic, Boris
    Hayward, Alison
    Wood, Lowell
    Eckhoff, Philip A.
    Nowak, Martin A.
    Langer, Robert
    Traverso, Giovanni
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [9] Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
    Margolis, David A.
    Gonzalez-Garcia, Juan
    Stellbrink, Hans-Juergen
    Eron, Joseph J.
    Yazdanpanah, Yazdan
    Podzamczer, Daniel
    Lutz, Thomas
    Angel, Jonathan B.
    Richmond, Gary J.
    Clotet, Bonaventura
    Gutierrez, Felix
    Sloan, Louis
    St Clair, Marty
    Murray, Miranda
    Ford, Susan L.
    Mrus, Joseph
    Patel, Parul
    Crauwels, Herta
    Griffith, Sandy K.
    Sutton, Kenneth C.
    Dorey, David
    Smith, Kimberly Y.
    Williams, Peter E.
    Spreen, William R.
    [J]. LANCET, 2017, 390 (10101) : 1499 - 1510
  • [10] Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials
    Nachega, Jean B.
    Parienti, Jean-Jacques
    Uthman, Olalekan A.
    Gross, Robert
    Dowdy, David W.
    Sax, Paul E.
    Gallant, Joel E.
    Mugavero, Michael J.
    Mills, Edward J.
    Giordano, Thomas P.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 58 (09) : 1297 - 1307
12